Stock listing
A2JGH0 Stock Price, News, Filings & Events — Hls Therapeutics, Inc.
Selected listing: A2JGH0 · LS · EUR · DE
This page tracks Hls Therapeutics, Inc.'s A2JGH0:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2JGH0:LS. A2JGH0:LS is the stock-level entry point for investors researching Hls Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2JGH0:LS
- Asset type
- Stock
- Market cap
- $82.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Hls Therapeutics, Inc. A2JGH0:LS stock context
This page tracks Hls Therapeutics, Inc.'s A2JGH0:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2JGH0:LS. A2JGH0:LS is the stock-level entry point for investors researching Hls Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Hls Therapeutics, Inc.
HLS Therapeutics Announces Q2 2026 Financial Results
August 12, 2026
HLS Therapeutics Provides Update on NILEMDO™ Market Access
August 5, 2026
HLS Therapeutics to Host Q2 2026 Financial Results Conference Call
July 29, 2026
HLS Therapeutics Announces Q1 2026 Financial Results
May 15, 2026
HLS Therapeutics to Host Q1 2026 Financial Results Conference Call
May 1, 2026
Hls Therapeutics, Inc. earnings calls
HLS Therapeutics Inc. (HLS) Q2 2026 Earnings Call
August 12, 2026 · Replay with transcript and chapters
HLS Therapeutics Inc. (HLS) Q1 2026 Earnings Call
May 15, 2026 · Replay with transcript and chapters
HLS Therapeutics Inc. (HLS) Q4 2025 Earnings Call
March 12, 2026 · Replay with transcript and chapters
HLS Therapeutics Inc. (HLS) Q3 2025 Earnings Call
November 13, 2025 · Replay with transcript and chapters
HLS Therapeutics Inc. (HLS) Q2 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
HLS Therapeutics Inc. (HLS) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Hls Therapeutics, Inc.
Hls Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A2JGH0:LS.
Hls Therapeutics, Inc. company profile
View the public company page for Hls Therapeutics, Inc. on 6ix.
Hls Therapeutics, Inc. news
Read company news and market updates connected to Hls Therapeutics, Inc..
Hls Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Hls Therapeutics, Inc..
Alternate listings
HLS:TSX
CA · CAD
Alternate listing for Hls Therapeutics, Inc.; the primary context on this page is A2JGH0:LS.
HLTRF:OTC
US · USD
Alternate listing for Hls Therapeutics, Inc.; the primary context on this page is A2JGH0:LS.
A2JGH0:LSX
DE · EUR
Alternate listing for Hls Therapeutics, Inc.; the primary context on this page is A2JGH0:LS.
74D:FWB
DE · EUR
Alternate listing for Hls Therapeutics, Inc.; the primary context on this page is A2JGH0:LS.
HLS:NEO
CA · CAD
Alternate listing for Hls Therapeutics, Inc.; the primary context on this page is A2JGH0:LS.